#Biopharma happenings#including deals#Actimed#Anaptysbio#GSK
#Agilent Technologies#Shares Acquired#DNB Asset#Asset Management#Technologies
#Certified Biobased#Biobased Resins#Sustainable Research#Sustainability Magazine#Magazine Cytiva
#Columns Market#Witness Remarkable#Remarkable Growth#HPLC Columns#openPR.com HPLC
#Keysight Technologies#Watch Heading#Zoom Communications#Monday Benzinga#Benzinga Zoom
#III Alzheimer#phase III#semaglutide fails#Nov.#III
#Nov. 17-21#ICYMI#top stories#Week#Nov.
#Nov. 17-21#biopharma stock#Biggest gainers#stock gainers#losers
#Nov. 17-21#med-tech stock#Med-tech gainers#stock gainers#Med-tech
#Agilent Technologies#Peak Advisors#Ensign Peak#Sells#Shares
#Agilent Technologies#Franklin Resources#Resources#Shares#Technologies
#coronavirus pandemic#ongoing coverage#BioWorld coronavirus#coronavirus articles#Free access
#Dayra Therapeutics#Versant-backed biotech#portfolio Newly#Newly launched#launched Dayra
#Fisher Scientific#Assessing Valuation#FDA Wins#Wins Expand#Expand Cancer
#Carolyn Bertozzi#Eli Lilly#SEC filing#Friday evening#evening SEC
#HHS Secretary#Secretary Robert#placing HHS#CDC alters#CDC website
#Eli Lilly#drugmaking peers#pharmaceutical company#success developing#developing medicines
#disease pipeline#eye disease#pipeline#spurred investments#maintain momentum